GTC Biotherapeutics (fka GTCB)

[jessellivermore]

Lighten up Lew

I was just trying at a little humour. Actually I appreciate your candor and ability to come off a point. I also understand your point about the sector in general. It has done poorly and is not in very good shape at present. My point is GTCB is not representative of the sector for the following reasons

a. They have a product that has a market approval. It will produce a revenue stream. Amount ???

b. They have a platform which IMHO as a grad of MIT and Harvard Med will be one of the most important in medical science.

c. They possess IP regarding protein manufacturing which could put them in a position in biotech similar to the one Msoft holds in CS.

d. IMHO the partnership with LFB is going to be far more important in helping the company survive the long grueling path the regulators set before the company.


I see no two dollar surrender in the future.